Evidence map›Paper›PMID 31462320›Full record

ArticleItalian journal of pediatrics2019

Clinical and genetic spectrum of interstitial lung disease in Chinese children associated with surfactant protein C mutations.

Da Hong, Dan Dai, Jing Liu, Congcong Zhang, Tingting Jin, Yanyan Shi, Gaoli Jiang, Mei Mei, Libo Wang, Liling Qian

Open access · goldAbstract read
In one paragraph

Article in Italian journal of pediatrics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Old and emerging therapies for childhood interstitial lung disease (chILD): a systematic review.European respiratory review : an official journal of the European Respiratory Society · 2026
    Pooled it
  2. Article
  3. Genetic Familial Interstitial Lung Disease.Clinics in chest medicine · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Da HongDepartment of Respiratory Medicine, Children's Hospital of Fudan University, No.399 Wanyuan Road, Shanghai, 201102, China.
Dan DaiChildren's Hospital of Fudan University, No.399 Wanyuan Road, Shanghai, 201102, China.
Jing LiuDepartment of Respiratory Medicine, Children's Hospital of Fudan University, No.399 Wanyuan Road, Shanghai, 201102, China.
Congcong ZhangDepartment of Respiratory Medicine, Children's Hospital of Fudan University, No.399 Wanyuan Road, Shanghai, 201102, China.
Tingting JinDepartment of Respiratory Medicine, Children's Hospital of Fudan University, No.399 Wanyuan Road, Shanghai, 201102, China.
Yanyan ShiDepartment of Respiratory Medicine, Children's Hospital of Fudan University, No.399 Wanyuan Road, Shanghai, 201102, China.
Gaoli JiangDepartment of Respiratory Medicine, Children's Hospital of Fudan University, No.399 Wanyuan Road, Shanghai, 201102, China.
Mei MeiDepartment of Respiratory Medicine, Children's Hospital of Fudan University, No.399 Wanyuan Road, Shanghai, 201102, China.
Libo WangDepartment of Respiratory Medicine, Children's Hospital of Fudan University, No.399 Wanyuan Road, Shanghai, 201102, China.
Liling QianDepartment of Respiratory Medicine, Children's Hospital of Fudan University, No.399 Wanyuan Road, Shanghai, 201102, China. llqian@126.com.
Children's Hospital of Fudan University · CN

Funding

Development Fund for Shanghai talents 201450National Natural Science Foundation of China 8167150
6 · The paper itself

Abstract

backgroundMutations in the surfactant protein C gene (SFTPC) result in interstitial lung disease (ILD). Our objective was to characterize clinical and genetic spectrum of ILD in Chinese children associated with SFTPC mutations.

methodsSix Chinese children with ILD heterozygous for SFTPC mutations were included. Candidate genes responsible for surfactant dysfunction were sequenced by next-generation sequencing. Subclones of SFTPC with novel mutations were generated and transiently transfected into A549 cells. The functional characterization of mutant surfactant protein C (SP-C) was evaluated by Western blotting and immunofluorescence.

resultsThe age of onset ranged from 7 days to 15 months. All cases required supplemental oxygen. Failure to thrive (5/6) was the most significant extra-pulmonary manifestation. Hydroxychloroquine was given as the long-term treatment of lung disease in four patients and two of them responded well. Three mutations were identified in six patients: four with I73T, one with D105G, one with Y113H. Mutations in three patients were inherited and three arised de novo. Western blotting revealed totally different band patterns between mutant SP-C (D105G and Y113H) and the wildtype. Immunofluorescence showed mutant SP-C (D105G) was scarcely trafficked to lamellar bodies but localized well to early endosomes, which was in marked contrast to the wildtype protein.

conclusionSFTPC mutations were an important cause of childhood ILD in Chinese population. I73T was a common SFTPC mutation in Chinese ILD children associated with surfactant protein C mutations.

Indexed as

Asian PeopleChinaCohort StudiesFemaleHumansInfantInfant, NewbornLung Diseases, InterstitialMaleMutationPulmonary Surfactant-Associated Protein CPulmonary Surfactant-Associated Protein CChineseInterstitial lung diseasesMutationSurfactant protein C

Identifiers

PMID31462320
PMCPMC6714457
OpenAlexW2970607287

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.